Regulon

Regulon: R-2318

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
161.6365410Pr-143Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
9689 ENSG00000082153 BZW1 Q7L1Q6
5216 ENSG00000108518 PFN1 P07737
2030 ENSG00000112759 SLC29A1 Q99808
55825 ENSG00000115425 PECR Q9BY49
6272 ENSG00000134243 SORT1 Q99523
10097 ENSG00000138071 ACTR2 P61160
79634 ENSG00000144306 SCRN3 Q0VDG4
9180 ENSG00000145623 OSMR Q99650
5051 ENSG00000158006 PAFAH2 Q99487
5580 ENSG00000163932 PRKCD Q05655
25932 ENSG00000169504 CLIC4 Q9Y696
4973 ENSG00000173391 OLR1 A0A024RAU0
5571 ENSG00000181929 PRKAG1 P54619
2760 ENSG00000196743 GM2A P17900
5660 ENSG00000197746 PSAP P07602
2342 ENSG00000257365 FNTB P49356

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
MIDOSTAURINKITSmall moleculeINHIBITORVascular endothelial growth factor receptor 2 inhibitor40
LONAFARNIBFNTASmall moleculeINHIBITORProtein farnesyltransferase inhibitor41
DIPYRIDAMOLESLC29A1Small moleculeINHIBITOR3',5'-cyclic phosphodiesterase inhibitor40
TIPIFARNIBFNTASmall moleculeINHIBITORProtein farnesyltransferase inhibitor32
SOTRASTAURINPRKD3Small moleculeINHIBITORProtein kinase C (PKC) inhibitor20
UCN-01CDK4Small moleculeINHIBITOR3-phosphoinositide dependent protein kinase-1 inhibitor20
DELCASERTIBPRKCDProteinINHIBITORProtein kinase C delta inhibitor20
GSK-690693PRKACBSmall moleculeINHIBITORProtein kinase C (PKC) inhibitor10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2318

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs